Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2020 16:59 ET | Source: Vaxcyte, Inc.

CORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update

FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Vaxcyte, Inc. (Nasdaq: PCVX), please note that in the first bullet under “Recent...
August 12, 2020 16:10 ET | Source: Vaxcyte, Inc.

Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update

FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
June 16, 2020 16:05 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

FOSTER CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
June 12, 2020 01:06 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces Pricing of Upsized Initial Public Offering

FOSTER CITY, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent...
June 03, 2020 08:30 ET | Source: Vaxcyte, Inc.

Vaxcyte Appoints Halley E. Gilbert to Board of Directors

FOSTER CITY, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
May 21, 2020 08:30 ET | Source: Vaxcyte, Inc.

SutroVax Announces Name Change to Vaxcyte

FOSTER CITY, Calif., May 21, 2020 (GLOBE NEWSWIRE) -- SutroVax, Inc., a next-generation vaccine company, today announced that it has changed its name to Vaxcyte, Inc. The new name more accurately...